Biocon Limited Intangible Assets

The latest intangible assets for BIOCON.NS is $100B as of June 2026. That compares with $100B in the prior-year period — up 1.5% year over year. Investors often review this figure alongside Biocon Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, BIOCON.NS's intangible assets moved from $100B to $100B — a 1.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Biocon Limited's operating scale or balance-sheet position.

A intangible assets figure of $100B for BIOCON.NS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting BIOCON.NS's intangible assets ($100B), review year-over-year change from $100B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Biocon Limited's intangible assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.